BIM
CPXX

BlackRock Investment Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

BlackRock Investment Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-127,214
Closed -$3.84M – 4084
2016
Q2 		$3.84M Buy
127,214
+122,722
+2,732% +$2.49M ﹤0.01% 1623
2016
Q1 		$50K Sell
4,492
-123
-3% -$403 ﹤0.01% 3276
2015
Q4 		$8K Buy
4,615
+523
+13% +$897 ﹤0.01% 3772
2015
Q3 		$7K Hold
4,092
– – ﹤0.01% 3850
2015
Q2 		$9K Buy
4,092
+449
+12% +$1.02K ﹤0.01% 3792
2015
Q1 		$9K Buy
3,643
+335
+10% +$902 ﹤0.01% 3714
2014
Q4 		$6K Buy
3,308
+443
+15% +$919 ﹤0.01% 3883
2014
Q3 		$7K Buy
+2,865
New +$7.84K ﹤0.01% 3826

BlackRock Investment Management's CPXX Position: Q3 2016 in Review

BlackRock Investment Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 127,214 shares — an estimated $3.84M sold.

BlackRock Investment Management first reported a position in CPXX in Q3 2014 and held it in 8 quarters. The position peaked at $3.84M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • BlackRock Investment Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 127,214 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $3.84M.
  • BlackRock Investment Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q3 2014 and held it in 8 quarters.
  • BlackRock Investment Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $3.84M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on BlackRock Investment Management's 13F filing for Q3 2016, filed 8 Nov 2016.